Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
. 2024 Mar 1;209(6):767. doi: 10.1164/rccm.v209erratum3

Erratum: The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial

PMCID: PMC10945062  PMID: 38488615

There are errors in a table in the article by Schweitzer and colleagues (1), published in the December 15, 2023 issue of the Journal. Because the data for one variable were incorrectly transcribed, in Table 3 the data in the second and third columns (“Baseline” and “Treatment”) have been corrected in the four rows underneath the row heading “ODI4 events/h.” The authors state that these changes do not affect the interpretation of the data.

For the convenience of our readers, the Journal is replacing the online version of the article with a corrected version.

Reference

  • 1. Schweitzer PK, Taranto-Montemurro L, Ojile JM, Thein SG, Drake CL, Rosenberg R, Corser B, Abaluck B, Sangal RB, Maynard J. The combination of aroxybutynin and atomoxetine in the treatment of obstructive sleep apnea (MARIPOSA): a randomized controlled trial. Am J Respir Crit Care Med . 2023;208:1316–1327. doi: 10.1164/rccm.202306-1036OC. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES